Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep 21;9(2):103-104.
doi: 10.4244/AIJ-E-23-00003. eCollection 2023 Sep.

New opportunities for bioresorbable scaffold technology

Adnan Kastrati  1   2 , Masaru Seguchi  1   3
Affiliations
Editorial

New opportunities for bioresorbable scaffold technology

Adnan Kastrati et al. AsiaIntervention. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

A. Kastrati is one of the inventors of a patent application from his institution related to drug-eluting stent technology. M. Seguchi has no conflicts of interest to declare.

References

    1. Cassese S, Byrne RA, Jüni P, Wykrzykowska JJ, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques JPS, Serruys PW, Windecker S, Kastrati A. Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials. EuroIntervention. 2018;13:1565–73. - PubMed
    1. Cassese S, Byrne RA, Ndrepepa G, Kufner S, Wiebe J, Repp J, Schunkert H, Fusaro M, Kimura T, Kastrati A. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet. 2016;387:537–44. - PubMed
    1. Seguchi M, Aytekin A, Lenz T, Nicol P, Alvarez-Covarrubias HA, Xhepa E, Klosterman GR, Beele A, Sabic E, Utsch L, Alyaqoob A, Joner M. Challenges of the newer generation of resorbable magnesium scaffolds: Lessons from failure mechanisms of the past generation. J Cardiol. 2023;81:179–88. - PubMed
    1. Shi Q, Zhang B, Wang X, JFei J, Qin Q, Zheng B, Chen M. Safety and efficacy of a novel three-dimensional printed bioresorbable sirolimus-eluting scaffold in a porcine model. AsiaIntervention. 2023;9:133–42. - PMC - PubMed
    1. Virmani R, Jinnouchi H, Finn AV. Discontinuity: Is it a Major Cause of Scaffold Thrombosis? J Am Coll Cardiol. 2017;70:2345–8. - PubMed

Publication types